Abstract: The present invention relates to a method of diagnosing depression in a subject. Specifically, the present invention relates to diagnosing depression in a subject by providing a sample of the microbiome from the subject; determining the quantitative level or presence of one or more bacterial species in the sample; and diagnosing depression based on the quantitative level or presence of the one or more bacterial species in the sample.

Abstract: The various embodiments of the present invention include systems and methods for monitoring, analyzing and virtually benchmarking system, process and/or assets. By breaking down each of a plurality of similarly configured processes, systems or assets into a desired level of component specificity and appropriately identifying such specificity in one or more databases, each component in each of the process, systems and/or assets can be compared separately and or in a group to similarly situated components and to a virtual benchmark obtained by a combination of each of the individually reported components.